Literature DB >> 28800952

The Best Single Measurement for Assessing Splenomegaly in Patients with Cirrhotic Liver Morphology.

Zachary Nuffer1, Thomas Marini2, Andrey Rupasov3, Stephen Kwak2, Shweta Bhatt4.   

Abstract

RATIONALE AND
OBJECTIVES: There is little agreement within the radiology literature as to the best single measurement for assessing splenomegaly. In this study, we evaluate the correlation of multiple unidirectional measurements of the spleen with splenic volume in patients with cirrhotic liver morphology on computed tomography (CT).
MATERIALS AND METHODS: Splenic volume was retrospectively calculated from CT examinations of 179 adult patients, 47 of whom were approved as renal donors, and 132 of whom were referred for various other indications, and were found to have cirrhotic liver morphology on CT. Seven unidimensional measurements (long-axis, cranial-caudal, width, and four measures of thickness) of each spleen were evaluated to identify which most closely correlated with the calculated volume.
RESULTS: The splenic width had the best correlation with splenic volume for mild-to-moderate splenomegaly, and the splenic cranial-caudal measurement had the best correlation with splenic volume for massive splenomegaly. Receiver operating characteristic analysis demonstrates that a splenic width measurement of approximately 10.5 cm has a sensitivity of 89% and a specificity of 78% for mild-to-moderate splenomegaly, and a cranial-caudal measurement of 14.6 cm has a sensitivity of 92% and a specificity of 91% for massive splenomegaly.
CONCLUSIONS: A splenic width threshold of 10.5 cm is the most sensitive (89%) and specific (78%) single measurement for mild-to-moderate splenomegaly in patients with cirrhotic liver morphology, whereas a cranial-caudal height threshold of 14.6 cm is the most sensitive (92%) and specific (91%) single measurement for massive splenomegaly.
Copyright © 2017 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Spleen; cirrhosis; measurement; portal hypertension; splenomegaly

Mesh:

Year:  2017        PMID: 28800952     DOI: 10.1016/j.acra.2017.06.006

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  6 in total

1.  Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers.

Authors:  Matteo Renzulli; Nicolò Brandi; Anna Pecorelli; Luigi Vincenzo Pastore; Alessandro Granito; Giuseppe Martinese; Francesco Tovoli; Mario Simonetti; Elton Dajti; Antonio Colecchia; Rita Golfieri
Journal:  Diagnostics (Basel)       Date:  2022-03-29

2.  Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.

Authors:  Lukas Müller; Felix Hahn; Aline Mähringer-Kunz; Fabian Stoehr; Simon Johannes Gairing; Friedrich Foerster; Arndt Weinmann; Peter Robert Galle; Jens Mittler; Daniel Pinto Dos Santos; Michael Bernhard Pitton; Christoph Düber; Uli Fehrenbach; Timo Alexander Auer; Bernhard Gebauer; Roman Kloeckner
Journal:  United European Gastroenterol J       Date:  2021-12-16       Impact factor: 4.623

3.  Associations between Chest CT Abnormalities and Clinical Features in Patients with the Severe Fever with Thrombocytopenia Syndrome.

Authors:  Hiroki Ashizawa; Kazuko Yamamoto; Nobuyuki Ashizawa; Kazuaki Takeda; Naoki Iwanaga; Takahiro Takazono; Noriho Sakamoto; Makoto Sumiyoshi; Shotaro Ide; Asuka Umemura; Masataka Yoshida; Yuichi Fukuda; Tsutomu Kobayashi; Masato Tashiro; Takeshi Tanaka; Shungo Katoh; Konosuke Morimoto; Koya Ariyoshi; Shimpei Morimoto; Mya Myat Ngwe Tun; Shingo Inoue; Kouichi Morita; Shintaro Kurihara; Koichi Izumikawa; Katzunori Yanagihara; Hiroshi Mukae
Journal:  Viruses       Date:  2022-01-28       Impact factor: 5.048

4.  Baseline Splenic Volume Outweighs Immuno-Modulated Size Changes with Regard to Survival Outcome in Patients with Hepatocellular Carcinoma under Immunotherapy.

Authors:  Lukas Müller; Simon Johannes Gairing; Roman Kloeckner; Friedrich Foerster; Arndt Weinmann; Jens Mittler; Fabian Stoehr; Tilman Emrich; Christoph Düber; Peter Robert Galle; Felix Hahn
Journal:  Cancers (Basel)       Date:  2022-07-22       Impact factor: 6.575

5.  Fully automated AI-based splenic segmentation for predicting survival and estimating the risk of hepatic decompensation in TACE patients with HCC.

Authors:  Lukas Müller; Roman Kloeckner; Aline Mähringer-Kunz; Fabian Stoehr; Christoph Düber; Gordon Arnhold; Simon Johannes Gairing; Friedrich Foerster; Arndt Weinmann; Peter Robert Galle; Jens Mittler; Daniel Pinto Dos Santos; Felix Hahn
Journal:  Eur Radiol       Date:  2022-04-08       Impact factor: 7.034

6.  Differential hepatic features presenting in Wilson disease-associated cirrhosis and hepatitis B-associated cirrhosis.

Authors:  Hao-Jie Zhong; Huan-Huan Sun; Lan-Feng Xue; Eileen M McGowan; Yu Chen
Journal:  World J Gastroenterol       Date:  2019-01-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.